مقاله‌های دارای تعهدات انتشار عمومی - Kenneth Pientaبیشتر بدانید
جای دیگری دردسترس نیست: ۵
مرور
Diagnostic liquid biopsy biomarkers in renal cell cancer‏
RC Zieren, PJ Zondervan, KJ Pienta, A Bex, TM de Reijke, AD Bins‏
Nature Reviews Urology 21 (3), 133-157, 2024‏
تعهدات: US National Institutes of Health‏
مرور
The CTSA mandate: are we there yet?‏
CM Sampselle, KJ Pienta, DS Markel‏
Research and theory for nursing practice 24 (1), 64-73, 2010‏
تعهدات: US National Institutes of Health‏
مرور
Game theory cancer models of cancer cell-stromal cell dynamics using interacting particle systems‏
Y Zheng, Y Sun, G Torga, K Pienta, R Austin‏
Biophysical Reviews and Letters 15 (03), 171-193, 2020‏
تعهدات: US National Science Foundation‏
مرور
Baseline PSMA‐PET/CT as a predictor of PSA persistence following radical prostatectomy in high‐risk nonmetastatic prostate cancer patients receiving neoadjuvant therapy‏
X Du, Y Dong, J Liu, Y Su, Y Zhu, J Pan, B Dong, R Chen, J Liu, Z Tong, ...‏
The Prostate 83 (11), 1112-1120, 2023‏
تعهدات: National Natural Science Foundation of China‏
مرور
A Multi-targeted Approach to Treating Bone Metastases‏
RD Loberg, KJ Pienta‏
Bone Cancer, 441-448, 2010‏
تعهدات: US National Institutes of Health‏
جای دیگری دردسترس است: ۳۳۱
مرور
Integrative clinical genomics of advanced prostate cancer‏
D Robinson, EM Van Allen, YM Wu, N Schultz, RJ Lonigro, JM Mosquera, ...‏
Cell 161 (5), 1215-1228, 2015‏
تعهدات: US National Institutes of Health, Howard Hughes Medical Institute, Cancer …‏
مرور
The mutational landscape of lethal castration-resistant prostate cancer‏
CS Grasso, YM Wu, DR Robinson, X Cao, SM Dhanasekaran, AP Khan, ...‏
Nature 487 (7406), 239-243, 2012‏
تعهدات: US National Institutes of Health, Howard Hughes Medical Institute, Doris …‏
مرور
Activating ESR1 mutations in hormone-resistant metastatic breast cancer‏
DR Robinson, YM Wu, P Vats, F Su, RJ Lonigro, X Cao, ...‏
Nature genetics 45 (12), 1446-1451, 2013‏
تعهدات: US National Institutes of Health, Howard Hughes Medical Institute, Doris …‏
مرور
Targeting the tumour stroma to improve cancer therapy‏
KC Valkenburg, AE De Groot, KJ Pienta‏
Nature reviews Clinical oncology 15 (6), 366-381, 2018‏
تعهدات: US National Institutes of Health‏
مرور
Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets‏
H Beltran, DS Rickman, K Park, SS Chae, A Sboner, TY MacDonald, ...‏
Cancer discovery 1 (6), 487-495, 2011‏
تعهدات: US National Institutes of Health‏
مرور
Outcomes of observation vs stereotactic ablative radiation for oligometastatic prostate cancer: the ORIOLE phase 2 randomized clinical trial‏
R Phillips, WY Shi, M Deek, N Radwan, SJ Lim, ES Antonarakis, SP Rowe, ...‏
JAMA oncology 6 (5), 650-659, 2020‏
تعهدات: US National Institutes of Health‏
مرور
CXCL12/CXCR4/CXCR7 chemokine axis and cancer progression‏
X Sun, G Cheng, M Hao, J Zheng, X Zhou, J Zhang, RS Taichman, ...‏
Cancer and metastasis reviews 29 (4), 709-722, 2010‏
تعهدات: US National Institutes of Health‏
مرور
Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing‏
DR Robinson, YM Wu, S Kalyana-Sundaram, X Cao, RJ Lonigro, ...‏
Nature genetics 45 (2), 180-185, 2013‏
تعهدات: US National Institutes of Health, Howard Hughes Medical Institute, Doris …‏
مرور
Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow‏
Y Shiozawa, EA Pedersen, AM Havens, Y Jung, A Mishra, J Joseph, ...‏
The Journal of clinical investigation 121 (4), 1298-1312, 2011‏
تعهدات: US National Institutes of Health‏
مرور
Polyclonal breast cancer metastases arise from collective dissemination of keratin 14-expressing tumor cell clusters‏
KJ Cheung, V Padmanaban, V Silvestri, K Schipper, JD Cohen, ...‏
Proceedings of the National Academy of Sciences 113 (7), E854-E863, 2016‏
تعهدات: US National Institutes of Health‏
مرور
Identification of targetable FGFR gene fusions in diverse cancers‏
YM Wu, F Su, S Kalyana-Sundaram, N Khazanov, B Ateeq, X Cao, ...‏
Cancer discovery 3 (6), 636-647, 2013‏
تعهدات: US National Institutes of Health, Howard Hughes Medical Institute, Doris …‏
مرور
The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex‏
JR Prensner, MK Iyer, A Sahu, IA Asangani, Q Cao, L Patel, IA Vergara, ...‏
Nature genetics 45 (11), 1392-1398, 2013‏
تعهدات: Swiss National Science Foundation, US National Institutes of Health, Howard …‏
مرور
Circulating tumour cells as prognostic markers in progressive, castration-resistant prostate cancer: a reanalysis of IMMC38 trial data‏
HI Scher, X Jia, JS de Bono, M Fleisher, KJ Pienta, D Raghavan, G Heller‏
The lancet oncology 10 (3), 233-239, 2009‏
تعهدات: US National Institutes of Health‏
مرور
Androgen receptor pathway-independent prostate cancer is sustained through FGF signaling‏
EG Bluemn, IM Coleman, JM Lucas, RT Coleman, S Hernandez-Lopez, ...‏
Cancer cell 32 (4), 474-489. e6, 2017‏
تعهدات: US Department of Defense, US National Institutes of Health‏
مرور
Personalized oncology through integrative high-throughput sequencing: a pilot study‏
S Roychowdhury, MK Iyer, DR Robinson, RJ Lonigro, YM Wu, X Cao, ...‏
Science translational medicine 3 (111), 111ra121-111ra121, 2011‏
تعهدات: US National Institutes of Health, Howard Hughes Medical Institute‏
اطلاعات انتشارات و تأمین بودجه به‌طورخودکار توسط برنامه رایانه‌ای تعیین می‌شود.